Another study reported that high levels of CD163+ TAMs within the subjectively selected most TAM-enriched breast cancer regions were significantly associated with aggressive features, such as vessel invasion and non-luminal molecular subgroups and reduced survival in a cohort of 282 patients [39]. Here, CD163 is linked to breast carcinoma.